pneumonia | CMAC

pneumonia

Ceftaroline: Before Start of Using in Russia

Bacteriological and clinical data on the novel cephalosporin antibiotic ceftarolin fosamil is reviewed. Ceftarolin may be considered as promising drug in Russia due to potent anti-MRSA and antipneumococcal activity, broad spectrum and low toxicity.

Methodology Issues of Legionella Pneumonia Diagnosis in Medical Institutions (Part 2)

Objective. To use algorithm of microbiologic and epidemiologic methods when detecting two or more cases of legionellosis in the medical institution, in accordance with the international guidelines and to assess its efficacy. Materials and Methods. A total of 76 hematological patients with pneumonia and acute respiratory failure were tested for legionellosis using bronchoalveolar lavage (BAL) fluid culture and Legionella urinary antigen test between December 2010 and January 2013. Water samples obtained from the institution’s hot water supply system were tested for Legionella by the standard microbiology method.

Analysis of Antiviral and Antibacterial Therapy in Patients with Influenza A/H1N1 and Pneumonia

Analyzing the cases of treatment of pneumonia with influenza A/H1N1 in the background, it was noted that the outpatient antiviral therapy was provided mainly by «Arbidol». Neuraminidase inhibitors (Oseltamivir and Zanamivir) were used very …

Methodology Issues of Legionella Pneumonia Diagnosis in Medical Institutions

Objective. To determine significance of Legionella pneumonia for hematological patients in ICUs, and to evaluate prospects of the proposed algorithm for diagnosis of legionellosis. Materials and Methods. A total of 37 hematological ICU patients were assessed for legionellosis between December 2010 and February 2012. Bronchoalveolar lavage (BAL) fluid culture and Legionella urinary antigen test (rapid immunochromatographic assay) were used to diagnose legionellosis. Results. Diagnosis of legionellosis was confirmed in 4 (11%) patients, of which 3 had fatal outcome.

Serological Characteristics and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children 0–5 Years of Age in Different Regions of Russia

This article presents results of the study on serotypes distribution of clinical and colonized strains of S. pneumoniae circulated in different regions of Russian Federation in children attended day-care centers and orphanages, and in pediatric …

Clinical and Laboratory Characteristics of Legionella Pneumonia Depending on Severity of the Disease

Objective. To determine characteristics of community-acquired Legionella pneumonia depending on severity of the disease, identify adverse reactions of long-term antimicrobial regimens, and calculate equation of prognosis of Legionella pneumonia severity upon hospital admission. Materials and Methods. A total of 61 patients with Legionella pneumonia were included and divided into 3 groups depending on the disease severity: Group 1 – 15 patients with non-severe pneumonia without systemic inflammatory response syndrome (SIRS), Group 2 – 32 patients with severe pneumonia and SIRS, Group 3 – 14 patients with very severe pneumonia.

Treatment of Hospitalized Patients with Pneumonia: Levofloxacin vs. Other Treatment Options

Translated and reprinted with permission from «Chemotherapie Journal» 2007; 16:41-8.

The main objective of this study was to compare the efficacy of levofloxacin in hospitalized patients suffering from pneumonia to other antibiotic options by …

Pneumonia in Nursing Homes: Current View on Problem

Pneumonia is the common bacterial infection among elderly patients in nursing homes and long-term care facilities. Pneumonia in that population is often severe and associated with high mortality. The high prevalence of this infection, diagnostic …

Clinical Features and Course of Pneumocystis Pneumonia in Non-HIV Patients

As a result of the increase in the number of diseases and conditions that are leading to secondary immunodeficiency, the problem of severe opportunistic infections becoming more and more actual.In the present article authors have described and …

Moxifloxacin: the Present and the Future in the Sequential Therapy

Moxifloxacin is a new broad spectrum 8-meth-oxiquinolon with high activity against both Gram(+) and Gram(–) microorganisms as well as against anaerobes and intracellular pathogens. It is also active against microorganisms that are resistant to other …